Abstract
Het overgrote deel van kinderen met Attention-Deficit/Hyperactivity Disorder (adhd) wordt behandeld met kortwerkende stimulantia. De laatste jaren zijn verschillende langer werkende medicijnen voor adhd ontwikkeld. In dit artikel wordt recent onderzoek naar Concerta, Adderall en andere langwerkende medicijnen besproken, evenals de stand van zaken in Nederland. In de discussie worden suggesties voor verder onderzoek gedaan en klinische implicaties besproken.
Similar content being viewed by others
Literatuur
Ahmann, P.A., Theye, F.W., Berg, R., Linguist, A.J. & Van Erem, A.J. (2001). Placebo-controlled evaluation of amphetamine mixture ’ dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics, 107(1), E10.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington: American Psychiatric Association.
Faraone, S.V., Biederman, J., & Roe, C. (2002). Comparative efficacy of Adderall en Methylphenidate in Attention-Deficit/Hyperactivity Disorder: a meta-analysis. Journal of Clinical Psychopharmacology, 22(5), 468-474.
Findling, R.L, Short, E.J. & Manos, M.J. (2001). Short-Term cardiovascular Effects of Methylphenidate and Adderall. Journal of the American Academy of Child and Adolescent Psychiatry 40(5), 525-529.
Manos, M.J., Short, E. & Findling, R.L. (1999). Differential effectiveness of methylphenidate and Adderall in school-age youths with Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 813-819.
Pelham, W.E., Aronoff, H.R., Midlam, J.K., Shapiro, C.J., & Gnagy, E.M. (1999a). A comparison of Ritalin and Adderall: efficacy and time-course in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics 103(4), 805-827.
Pelham, W.E., Gnagy, E.M., & Chronis, A.M. (1999b). A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily Methylphenidate in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 104(6), 1300-1311.
Pelham, W.E., Gnagy, E.M., & Burrows, L. (2001). Once a day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics, 107(6), E105.
Pliszka, S.R., Browne, R.G., Olvera, R., & Wynne, S.K. (2000). A double-blind placebo-controlled study of Adderall and methylphenidate in the treatment of Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 619-626.
Popper, C.W. (1994). The story of four salts. Journal of Child and Adolescent Psychopharmacology, 4, 217-223.
Steinhoff, K.W. (2003). Stimulants more effective than atomoxetine for once-daily treatment of Attention-Deficit/Hyperactivity Disorder. Presentation at the 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry.
Swanson, J. (2003). Compliance with stimulants for Attention-Deficit/Hyperactivity Disorder. cns Drugs, 17(2), 117-131.
Swanson, J.M., Gupta, S., Lam, A, Shoulson, I., & Lerner, M. (2003). Development of a new once-a-day formulation of methylphenidate for the treatment of Attention-Deficit/Hyperactivity Disorder: proof-of-concept and proof-of-product studies. Archives of General Psychiatry, 60, 204-211.
Swanson, J.M., Wigal, S, Greenhill, L.L., Browne, R. & Waslik, B. (1998). Analog Classroom Assessment of Adderall in Children with adhd. Journal of the American Academy of Child and Adolescent Psychiatry, 37(5), 519-526.
Wilens, T., Pelham, W., Stein, M., Conners, K., & Abikoff, H. (2003). adhd treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 424-433.
Wolraich, M.L., Greenhill, L.L., Pelham, W., Swanson, J., & Wilens T. (2001). Randomized, controlled trial of OROS methylphenidate once a day in children with Attention-Deficit/Hyperactivity Disorder. Pediatrics, 108(4), 883-893.
Author information
Authors and Affiliations
Corresponding author
Additional information
L. Oppenmeer, psychologe, ggz-centrum West Friesland, Maelsonstraat 1, 1624 NP Hoorn
S. van der Oord, psychologe, aio, Faculteit der Maatschappij en Gedragswetenschappen, Universiteit van Amsterdam, Afdeling Klinische Psychologie, Roeterstraat 15, 1018 WB Amsterdam
P.E. Maidman, kinder-en jeugdpsychiater, Regionaal Centrum Kinder-en Jeugdpsychiatrie Gooi en Vechtstreek (Symfora Groep en de Bascule), Olmenlaan 159, 1404 DE Bussum neuropsychologe, Afdeling Neurologie, hpn G03.228, Universitair Medisch Centrum Utrecht, Postbus 85500, 3508 GA Utrecht.
Rights and permissions
About this article
Cite this article
Oppenmeer, L., van der Oord, S. & Maidman, P. Medicatiebehandeling van ADHD: nieuwe ontwikkelingen. NEPR 8, 69–73 (2004). https://doi.org/10.1007/BF03079003
Issue Date:
DOI: https://doi.org/10.1007/BF03079003